Here are some news/notes from a day in MedCity, Minnesota:
American Medical Systems Inc. on Tuesday announced that it has sold its Her Option Global Endometrial Ablation product line to a Cooper Surgical for $20.5 million, according to the Minneapolis-St. Paul Business Journal. Cooper Surgical is a subsidiary of Pleasanton, Calif.-based Coopers Companies Inc., which develops, manufactures and markets health care products for the vision care and women’s health markets.
SurModics Inc., a pharmaceutical company based in Eden Prairie, is planning to terminate a licensing agreement with Ambrilia Biopharma Inc. in Canada. Ambrilia said it disagrees with SurModics contention that it’s not adequately developing Octreotide, a cancer drug. Ambrilia said it’s continuing to negotiate with SurModics but exploring legal options.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Mayo Clinic recently launched an initiative to reduce avoidable hospital readmissions, starting with three high-risk conditions: heart failure, heart attack and pneumonia, according to the Jacksonville Business Journal. The number of patients discharged and readmitted to a hospital within 30 days has become a red flag in health care, prompting a nationwide focus on eliminating unnecessary hospital readmissions.
Gov. Tim Pawlenty’s budget calls for the University of Minnesota to receive $100 million in bonding, half that amount devoted to a new physics and nanotechnology facility, according to Finance & Commerce in Minneapolis.
3M Cos of Maplewood has donated some of its royalty-bearing patents to the University of Minnesota’s law school and Office for Technology Commercialization, according to the Minneapolis-St. Paul Business Journal. The law school has established a 3M Fund for Law, Science and Technology to support various programs and initiatives in teaching and research. The OTC part of the University’s efforts to move research into the marketplace.
